JP2009538852A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538852A5
JP2009538852A5 JP2009512481A JP2009512481A JP2009538852A5 JP 2009538852 A5 JP2009538852 A5 JP 2009538852A5 JP 2009512481 A JP2009512481 A JP 2009512481A JP 2009512481 A JP2009512481 A JP 2009512481A JP 2009538852 A5 JP2009538852 A5 JP 2009538852A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
pyrido
imidazo
pyrazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009512481A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/004747 external-priority patent/WO2007137819A1/en
Publication of JP2009538852A publication Critical patent/JP2009538852A/ja
Publication of JP2009538852A5 publication Critical patent/JP2009538852A5/ja
Pending legal-status Critical Current

Links

JP2009512481A 2006-05-30 2007-05-29 4−アミノ−ピリド[3,2−e]ピラジン、該化合物のホスホジエステラーゼ10の阻害剤としての使用、及び該化合物の製造方法 Pending JP2009538852A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80925106P 2006-05-30 2006-05-30
PCT/EP2007/004747 WO2007137819A1 (en) 2006-05-30 2007-05-29 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM

Publications (2)

Publication Number Publication Date
JP2009538852A JP2009538852A (ja) 2009-11-12
JP2009538852A5 true JP2009538852A5 (enExample) 2010-07-15

Family

ID=38441601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009512481A Pending JP2009538852A (ja) 2006-05-30 2007-05-29 4−アミノ−ピリド[3,2−e]ピラジン、該化合物のホスホジエステラーゼ10の阻害剤としての使用、及び該化合物の製造方法

Country Status (13)

Country Link
US (1) US20070299079A1 (enExample)
EP (1) EP2021341A1 (enExample)
JP (1) JP2009538852A (enExample)
CN (1) CN101448829A (enExample)
AR (1) AR060984A1 (enExample)
AU (1) AU2007267391A1 (enExample)
BR (1) BRPI0711857A2 (enExample)
CA (1) CA2653412A1 (enExample)
CL (1) CL2007001555A1 (enExample)
MX (1) MX2008015308A (enExample)
PE (1) PE20080266A1 (enExample)
TW (1) TW200815436A (enExample)
WO (1) WO2007137819A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2671980C (en) * 2006-12-13 2015-05-05 Aska Pharmaceutical Co., Ltd. Quinoxaline derivatives
US20090143392A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Methods of Treating Obesity and Metabolic Disorders
US7875618B2 (en) * 2007-11-30 2011-01-25 Wyeth Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders
US20090143361A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
WO2010054260A1 (en) * 2008-11-07 2010-05-14 Biotie Therapies Gmbh Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
JP5911476B2 (ja) 2010-05-26 2016-04-27 スノビオン プハルマセウトイカルス インコーポレイテッド ヘテロアリール化合物及びその使用方法
DE102010042833B4 (de) 2010-10-22 2018-11-08 Helmholtz-Zentrum Dresden - Rossendorf E.V. Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung
US9540379B2 (en) 2011-01-31 2017-01-10 Boehringer Ingelheim International Gmbh (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
KR20140009372A (ko) 2011-02-18 2014-01-22 알러간, 인코포레이티드 포스포다이에스테라제 10(pde10a)의 억제제로서의 치환된 6,7-다이알콕시-3-아이소퀴놀리놀 유도체
US9938269B2 (en) 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
WO2013034761A1 (en) * 2011-09-09 2013-03-14 H. Lundbeck A/S Pyridine compounds and uses thereof
HK1211023A1 (zh) 2011-10-10 2016-05-13 H. Lundbeck A/S 具有咪唑并吡嗪骨架pde9i
SG11201402134VA (en) 2011-11-09 2014-06-27 Abbvie Deutschland Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
US20130116241A1 (en) 2011-11-09 2013-05-09 Abbvie Inc. Novel inhibitor compounds of phosphodiesterase type 10a
AP2014007820A0 (en) 2012-01-26 2014-07-31 Lundbeck & Co As H PDE9 inhibitors with imidazo triazinone backbone
PE20142258A1 (es) 2012-04-25 2015-01-15 Takeda Pharmaceutical Compuesto heterociclico nitrogenado
NZ702239A (en) 2012-06-19 2017-01-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof
EP2873669A4 (en) 2012-07-13 2015-11-25 Takeda Pharmaceutical HETEROCYCLIC CONNECTION
US20140045856A1 (en) * 2012-07-31 2014-02-13 Boehringer Ingelheim International Gmbh 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
US9464085B2 (en) * 2012-08-17 2016-10-11 AbbVie Deutschland GmbH & Co. KG Inhibitor compounds of phosphodiesterase type 10A
EP2895489B1 (en) 2012-09-17 2017-10-18 AbbVie Deutschland GmbH & Co. KG Novel inhibitor compounds of phosphodiesterase type 10a
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9790203B2 (en) 2012-11-26 2017-10-17 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US9200005B2 (en) 2013-03-13 2015-12-01 AbbVie Deutschland GmbH & Co. KG Inhibitor compounds of phosphodiesterase type 10A
MX2015012008A (es) 2013-03-14 2016-04-15 Abbvie Deutschland Compuestos inhibidores novedosos de fosfodiesterasa tipo 10a.
US9834520B2 (en) 2013-03-14 2017-12-05 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP6411342B2 (ja) 2013-07-03 2018-10-24 武田薬品工業株式会社 アミド化合物
WO2015002231A1 (ja) 2013-07-03 2015-01-08 武田薬品工業株式会社 複素環化合物
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
CN103980281B (zh) * 2014-05-27 2016-06-08 天津市斯芬克司药物研发有限公司 一种咪唑吡嗪化合物及其制备方法
IL280619B2 (en) 2015-07-07 2023-10-01 H Lundbeck As Phosphodiesterase 9 inhibitors with an imidazo triazinon or imidazo pyrazinone skeleton for the treatment of peripheral diseases
EP4349403A3 (en) 2018-05-25 2024-06-05 Cardurion Pharmaceuticals, Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one
MA53501A (fr) 2018-08-31 2021-07-07 Imara Inc Inhibiteurs de pde9 pour le traitement de la drépanocytose
WO2020065583A1 (en) 2018-09-28 2020-04-02 Takeda Pharmaceutical Company Limited Balipodect for treating or preventing autism spectrum disorders
CN114524808B (zh) * 2022-02-21 2023-10-24 深圳市儿童医院 一种吡唑衍生物及其作为pde10抑制剂的用途
CN114524806B (zh) * 2022-02-22 2024-09-03 深圳市儿童医院 一种三氮唑衍生物及其作为pde10抑制剂的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002505330A (ja) * 1998-03-04 2002-02-19 ブリストル−マイヤーズ スクイブ カンパニー ヘテロシクロ−置換イミダゾピラジン・たんぱくチロシンキナーゼ抑制剤
JPH11292878A (ja) * 1998-04-09 1999-10-26 Yamanouchi Pharmaceut Co Ltd イミダゾナフチリジン誘導体
IL149106A0 (en) * 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
US20030032579A1 (en) * 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them

Similar Documents

Publication Publication Date Title
JP2009538852A5 (enExample)
EP3317289B1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
AU2016256728B2 (en) Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions
JP5658664B2 (ja) 1,2−二置換複素環式化合物
CN101678014B (zh) 杂环激酶调节剂
CA2866143C (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
CN115448910A (zh) 一种哒嗪类衍生物抑制剂、其制备方法和应用
US20090239874A1 (en) Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing them
JP2009538853A5 (enExample)
JP6600319B2 (ja) ヒストンデアセチラーゼ阻害薬及び組成物並びにそれらの使用の方法
US20070299079A1 (en) 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
JP2017515863A (ja) 脊髄性筋萎縮症を処置するための化合物
CN102164604A (zh) 用作激酶调节剂的稠合杂环化合物
AU2013355054B2 (en) Diazole lactams
JP2020532585A (ja) インターフェロン遺伝子刺激因子調節薬としての環状ジヌクレオチド
RS63581B1 (sr) Inhibitori p38 kinaze smanjuju ekspresiju dux4 i nizvodnih gena u cilju lečenja fshd
CN102388055A (zh) 咪唑并[2,1-b][1,3,4]噻二唑衍生物
CN106008479A (zh) 作为磷脂酰肌醇3-激酶δ抑制剂的取代嘧啶类化合物及其应用
AU2011258005A1 (en) Heterocyclic compounds as Janus kinase inhibitors
CN114605387A (zh) 取代的苯并咪唑、它们的制备和它们作为药物的用途
RS52838B (sr) Fenoksimetil heterociklična jedinjenja
CN105936635A (zh) 作为磷脂酰肌醇3-激酶δ抑制剂的化合物及其应用
CN106414459B (zh) 作为pde1抑制剂的六氢呋喃并吡咯
CN105985354B (zh) 嘧啶衍生物、细胞毒性剂、药物组合物及其应用
TW201215607A (en) Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor